ORGANIZATION AND EFFICACY OF A THERAPEUTIC DRUG-MONITORING CONSULTATION SERVICE IN A PEDIATRIC HOSPITAL

被引：15

作者：

KOREN, G

SOLDIN, SJ

MACLEOD, SM

机构：

[1] HOSP SICK CHILDREN,THERAPEUT DRUG MONITORING LAB,TORONTO M5G 1X8,ONTARIO,CANADA

[2] UNIV TORONTO,DEPT PEDIAT,TORONTO M5S 1A1,ONTARIO,CANADA

[3] UNIV TORONTO,DEPT PHARMACOL,TORONTO M5S 1A1,ONTARIO,CANADA

来源：

THERAPEUTIC DRUG MONITORING | 1985年 / 7卷 / 03期

关键词：

D O I：

10.1097/00007691-198507030-00010

中图分类号：

R446 [实验室诊断]; R-33 [实验医学、医学实验];

学科分类号：

1001 ;

摘要：

引用

页码：295 / 298

页数：4

共 12 条

[1]

BALANT L, 1983, HDB CLIN PHARMACOKIN, P212

[2] DIFFICULTY IN ACHIEVING THERAPEUTIC SERUM CONCENTRATIONS OF SALICYLATE IN KAWASAKI DISEASE [J].

KOREN, G ;

MACLEOD, SM .

JOURNAL OF PEDIATRICS, 1984, 105 (06) :991-995

[3]

KOREN G, 1984, PEDIATR PHARMACOL, V4, P25

[4]

KOREN G, 1983, CAN MED ASSOC J, V129, P721

[5]

KOREN G, 1985, PEDIATR PHARMACOL, V5, P79

[6]

KOREN G, 1985, PEDIATRICS, V75, P1032

[7]

KRAEMER MJ, 1982, PEDIATRICS, V69, P476

[8] DEPRESSION OF THEOPHYLLINE ELIMINATION BY ERYTHROMYCIN [J].

RENTON, KW ;

GRAY, JD ;

HUNG, OR .

CLINICAL PHARMACOLOGY & THERAPEUTICS, 1981, 30 (03) :422-426

[9]

TAYLOR WJ, 1981, INDIVIDUALIZING DRUG

[10]

TOZER TN, 1980, APPLIED PHARMACOKINE, P217

← 1 2 →